AMA welcomes CDC’s revised view on opioids guidelines
The AMA continues to urge informed prescribing to reduce opioid-related harm and appreciates the CDC recognizes that patients require individualized care.
Arkansas sets standard for states by removing prior authorization for treatment of opioid use disorder
The AMA and AMS commended Governor Asa Hutchinson and the General Assembly for removing administrative barriers to treatment for opioid use disorder (OUD).
Anyone can save a life with naloxone: What patients should know
The signs of an overdose, how to administer naloxone, and the toll of stigma covered by experts in a presentation at AMA’s Chicago headquarters.
AMA supports FDA’s changes to prescription opioids labels
AMA welcomes FDA including tapering guidance on prescription opioid labels, changes mirror points that AMA has emphasized in efforts to end the opioid epidemic.
Quick Take: Moves cut barriers to opioid-use disorder treatment
In actions that will save lives, New Jersey and Washington, D.C., removed prior authorization for Medicaid patients who need medication-assisted treatment.
Health insurance industry slow to adopt prior authorization reforms
Despite potentially harmful consequences of delayed care, health plans not making progress reforming prior authorization process they impose on patient care.
HHS official: Better pain treatment a key to ending opioid crisis
HHS official says two keys to ending the opioid epidemic are finding better ways to treat pain and moving from a crisis framework to a sustainable system.
AMA presents government service award to FDA commissioner
The AMA presented FDA Commissioner Scott Gottlieb, MD, with the Dr. Nathan Davis Award for Outstanding Government Service.
AMA presents government service award to Governor Charlie Baker
The AMA presented MA Gov. Charlie Baker with the Dr. Nathan Davis Award for Outstanding Government Service for his decisive action to fight the opioid epidemic.